TrialNature medicine2025

Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Elisabeth M Jongbloed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.